MedTrace Logo

BDNF Promoter Methylation: Effects on Cognition, Stress and Anxiety and Depression Symptom in Healthy Women.

NCT04955457 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-07-13

No results posted yet for this study

Summary

The purpose of this study is to explore the association between BDNF methylation and neurocognitive performance, perceived stress, and well-being in healthy women.

Conditions

  • BDNF
  • Memory Impairment
  • Stress
  • Well-being
  • Methylation

Interventions

OTHER

Healthy women active teachers

The neuropsychological testing data, psychometric measure, demographic, clinical and lifestyle information and blood samples were collected at similar time points. This group not received any intervention.

Sponsors & Collaborators

  • Federal University of São Paulo

    collaborator OTHER

  • Ana Flávia Marçal Pessoa

    lead OTHER

Principal Investigators

  • Daniela Rodrigues de Oliveira, PhD · Federal University of São Paulo

Eligibility

Min Age
23 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-06-01
Completion
2019-06-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04955457 on ClinicalTrials.gov